Abattis Bioceuticals (ATTBF) 1.0300 $ATTBF
Abattis Announces the Acquisition of 34% Interest in Instant Payment Systems LLC
ACCESSWIRE - Thu May 01, 5:15PM CDT
Vancouver, BC / ACCESSWIRE / May 1, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), through its wholly owned Washington subsidiary Abattis Bioceuticals International Inc. is pleased to announce that it has acquire 34% interest in Instant Payment Systems LLC (IPS), a US entity based in Washington State, in consideration for 200,000 common shares at a deemed price of CDN $1.15/share and CDN 100,000. Under the terms of the agreement Abattis will receive 60% economic interest with the responsibility of being the marketing and sales arm of the organization.
Abattis Announces Shares For Debt & Corporate Presentation Announcement
ACCESSWIRE - Wed Apr 30, 10:37PM CDT
Vancouver, BC / ACCESSWIRE / April 30, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), The Company wishes to announce that pursuant to two consulting agreements with arm's length parties, it has issued an aggregate of 33,669 common shares at a deemed price of CAD 0.99/share as consideration for services provided to the Company.
CannabisFN Weekly: 4/20 Brings Cannabis Further into the Mainstream
ACCESSWIRE - Mon Apr 28, 8:01AM CDT
Whitefish, MT / April 28, 2014 / The Marijuana Index(tm) moved higher last week thanks in large part to GW Pharmaceuticals plc's (NASDAQ: GWPH) ~40% move higher. With a $937 million market capitalization, the company accounts for nearly 21% of the index. The move higher helped offset CannaVEST Corp.'s (OTCBB: CANV) ~68% and came a time when marijuana advocates celebrated the 4/20 holiday across the nation.
Abattis Announces Up To $2m Private Placement
ACCESSWIRE - Thu Apr 24, 12:03AM CDT
Vancouver, BC / ACCESSWIRE / April 23, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT) wishes to announce a proposed private placement of up to $2,000,000.
Terra Tech Corp. Releases Revenue Guidance of $7 Million for 2014
ACCESSWIRE - Wed Apr 23, 8:56AM CDT
Terra Tech Corp. (OTCQB: TRTC) recently released a corporate update and revenue guidance of $7,000,000 for the full year 2014.
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion
ACCESSWIRE - Thu Apr 17, 9:00AM CDT
On Apr. 16, Abattis Bioceuticals Corp. (OTCPINK: ATTBF) share volume soared, with 1,166,632 changing hands, significantly higher than its three-month average
CannabisFN Weekly: Regulatory Halts Cause Anxiety in Pot Stocks
ACCESSWIRE - Mon Apr 14, 8:04AM CDT
Whitefish, MT / April 14, 2014 / The Marijuana Index™ moved slightly lower last week amid a sell-off in the broader indices and concerns about compliance among pot stocks. Just as Advanced Cannabis Solutions Inc. (OTCBB: CANN) resumed trading, GrowLife Inc. (OTCBB: PHOT) was halted amid concerns about its disclosures and stock sales. The series of regulatory halts has led to significant anxiety among cannabis investors.
Abattis Announces Completes Agreement With Experion
ACCESSWIRE - Thu Apr 10, 8:21AM CDT
VANCOUVER, BC / ACCESSWIRE / April 10th, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), through its wholly owned subsidiary, Northern Vine Canada Inc. ("Northern Vine" , announces that it has entered into a share exchange agreement with Experion Biotechnologies Inc. ("Experion" . Pursuant to the terms of the agreement, Experion and Northern Vine have exchanged 25% of each parties' issued and outstanding common shares. Abattis maintains a 75% ownership in Northern Vine.
Abattis Completes Acquisiton Of Controlling Interest In Phytalytics LLC
ACCESSWIRE - Mon Apr 07, 9:18PM CDT
VANCOUVER, BC / ACCESSWIRE / April 7 , 2014 / Abattis Bioceuticals Corp. ("Abattis" or the "Company" (CSE: ATT) (OTC: ATTBF), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that further to its previous press release dated March 6, 2014 disclosing it had entered into consulting agreements with the principals of Phytalytics LLC of Kirkland, Washington, USA, the Company has acquired a 51% membership interest in Phytalytics LLC (doing business as Phytalab.com ).
Abattis Bioceuticals Corp. engages TDM Financial as Investor Relations Firm
ACCESSWIRE - Mon Apr 07, 8:22AM CDT
VANCOUVER, BC / ACCESSWIRE / April 7, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on the North American cannabis market, today announced the retention of TDM Financial as its full service investor relations firm to provide online branding, marketing, outreach, and investor relations management services. TDM Finacial also owns and operates CannabisFN.com a leading financial network serving the medical marijuana (MMJ) and cannabis industries.
Abattis Announces Grant Of Options
ACCESSWIRE - Mon Mar 31, 3:13PM CDT
Vancouver, BC / ACCESSWIRE / March 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), wishes to announce that it has granted incentive stock options to directors, officers and consultants of the Company to purchase up to an aggregate of 500,000 common shares of the Company. The options are exercisable on or before March 31, 2019, at an exercise price of $2.00 per share.
Abattis Announces Shares For Debt Settlement
ACCESSWIRE - Mon Mar 31, 1:39PM CDT
Vancouver, BC / ACCESSWIRE / March 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), announces the Company has reached a debt settlement arrangement with a service provider which is related to one of its directors in relation to an aggregate of US$62,554 debt owed to the service provider. Under the terms of the agreement, the Company proposes to issue an aggregate of 43,440 shares at a deemed price of US$1.44 (approx. CAD$1.60) per share.
OTC Daily Alert Stock Watch - Abattis Bioceuticals Corp. (OTC: ATTBF)
WorldStockWire - Fri Mar 28, 9:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
CannabisFN Weekly: Stocks Rally Ahead of Canada's MMPR Implementation
ACCESSWIRE - Mon Mar 24, 8:02AM CDT
Whitefish, MT / March 24, 2014 / The Marijuana Index™ moved lower last week due to a fall in GW Pharmaceuticals plc (OTCBB: GWPH), which accounts for 15.81% of the market capitalized weighted index, but these losses were offset by gains in many other components of the index. Investors have also been eyeing the upcoming MMPRs in Canada, which are set to become law on April 1, 2014, as well as ongoing favorable regulations in the United States.
Canadian Federal Court Judge's MMPR Injunction Very Positive for Abattis.
ACCESSWIRE - Sun Mar 23, 7:57PM CDT
Vancouver, BC / ACCESSWIRE / March 24, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), is pleased to comment on Canadian Federal judge Justice Michael D. Manson's ruling on March 21, 2014.
Tranzbyte and ATTBF Sign Letters of Intent Creating Strategic Production, Sales, and Distribution Partnership
Marketwire - Fri Mar 21, 9:00AM CDT
Tranzbyte Corporation (OTC Pink: ERBB)(PINKSHEETS: ERBB) (http://www.bloomberg.com/quote/ERBB:US) announced today that it has signed a Letter of Intent to form a strategic partnership with Abattis (OTC Pink: ATTBF)(PINKSHEETS: ATTBF) (CSE: ATT) (http://www.bloomberg.com/quote/ATTBF:US) to sell, market or otherwise license one another's products in their respective regions. Once the arrangement is completed, Tranzbyte will have access to Abattis's expanding suite of bio-ceutical grow products found in the Biocube Green Grow Systems for cultivation (LED's, Nutrients - Natures Juice). In addition Abattis owns proprietary flash freeze extraction technology, which produces high-grade cannabis and other botanical extracts. Conversely, Abattis will have the Canadian rights to distribute ZaZZZ(TM) and will pair Tranzbyte's Jurassic O2 water systems with its Biocube Green Grow Systems sales efforts in the US.
Abattis Announces Closing of $2.4M Financing and Option Grant
ACCESSWIRE - Wed Mar 19, 12:43PM CDT
Vancouver, BC / ACCESSWIRE / March 19, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), is pleased to announce that further to its news release of March 4, 2014, it has now closed a non-brokered private placement of 5,333,333 units for gross proceeds of $2.4M.
Abattis Corporate Update
ACCESSWIRE - Tue Mar 18, 9:49PM CDT
Vancouver, BC / ACCESSWIRE / March 18, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis" (OTC PINK: ATTBF) (CSE: ATT), wishes to provide a corporate update to inform shareholders of managements activities and focus.
Abattis Announces the Acquisition of 34% Interest in Instant Payment Systems LLC
ACCESSWIRE - Thu May 01, 5:15PM CDT
Vancouver, BC / ACCESSWIRE / May 1, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), through its wholly owned Washington subsidiary Abattis Bioceuticals International Inc. is pleased to announce that it has acquire 34% interest in Instant Payment Systems LLC (IPS), a US entity based in Washington State, in consideration for 200,000 common shares at a deemed price of CDN $1.15/share and CDN 100,000. Under the terms of the agreement Abattis will receive 60% economic interest with the responsibility of being the marketing and sales arm of the organization. Abattis Announces Shares For Debt & Corporate Presentation Announcement
ACCESSWIRE - Wed Apr 30, 10:37PM CDT
Vancouver, BC / ACCESSWIRE / April 30, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), The Company wishes to announce that pursuant to two consulting agreements with arm's length parties, it has issued an aggregate of 33,669 common shares at a deemed price of CAD 0.99/share as consideration for services provided to the Company. CannabisFN Weekly: 4/20 Brings Cannabis Further into the Mainstream
ACCESSWIRE - Mon Apr 28, 8:01AM CDT
Whitefish, MT / April 28, 2014 / The Marijuana Index(tm) moved higher last week thanks in large part to GW Pharmaceuticals plc's (NASDAQ: GWPH) ~40% move higher. With a $937 million market capitalization, the company accounts for nearly 21% of the index. The move higher helped offset CannaVEST Corp.'s (OTCBB: CANV) ~68% and came a time when marijuana advocates celebrated the 4/20 holiday across the nation.
Abattis Announces Up To $2m Private Placement
ACCESSWIRE - Thu Apr 24, 12:03AM CDT
Vancouver, BC / ACCESSWIRE / April 23, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT) wishes to announce a proposed private placement of up to $2,000,000. Terra Tech Corp. Releases Revenue Guidance of $7 Million for 2014
ACCESSWIRE - Wed Apr 23, 8:56AM CDT
Terra Tech Corp. (OTCQB: TRTC) recently released a corporate update and revenue guidance of $7,000,000 for the full year 2014.
Abattis Bioceuticals Corp. Enters Into Share Agreement with Experion
ACCESSWIRE - Thu Apr 17, 9:00AM CDT
On Apr. 16, Abattis Bioceuticals Corp. (OTCPINK: ATTBF) share volume soared, with 1,166,632 changing hands, significantly higher than its three-month average
CannabisFN Weekly: Regulatory Halts Cause Anxiety in Pot Stocks
ACCESSWIRE - Mon Apr 14, 8:04AM CDT
Whitefish, MT / April 14, 2014 / The Marijuana Index™ moved slightly lower last week amid a sell-off in the broader indices and concerns about compliance among pot stocks. Just as Advanced Cannabis Solutions Inc. (OTCBB: CANN) resumed trading, GrowLife Inc. (OTCBB: PHOT) was halted amid concerns about its disclosures and stock sales. The series of regulatory halts has led to significant anxiety among cannabis investors.
Abattis Announces Completes Agreement With Experion
ACCESSWIRE - Thu Apr 10, 8:21AM CDT
VANCOUVER, BC / ACCESSWIRE / April 10th, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), through its wholly owned subsidiary, Northern Vine Canada Inc. ("Northern Vine" , announces that it has entered into a share exchange agreement with Experion Biotechnologies Inc. ("Experion" . Pursuant to the terms of the agreement, Experion and Northern Vine have exchanged 25% of each parties' issued and outstanding common shares. Abattis maintains a 75% ownership in Northern Vine. Abattis Completes Acquisiton Of Controlling Interest In Phytalytics LLC
ACCESSWIRE - Mon Apr 07, 9:18PM CDT
VANCOUVER, BC / ACCESSWIRE / April 7 , 2014 / Abattis Bioceuticals Corp. ("Abattis" or the "Company"
(CSE: ATT) (OTC: ATTBF), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that further to its previous press release dated March 6, 2014 disclosing it had entered into consulting agreements with the principals of Phytalytics LLC of Kirkland, Washington, USA, the Company has acquired a 51% membership interest in Phytalytics LLC (doing business as Phytalab.com ). Abattis Bioceuticals Corp. engages TDM Financial as Investor Relations Firm
ACCESSWIRE - Mon Apr 07, 8:22AM CDT
VANCOUVER, BC / ACCESSWIRE / April 7, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on the North American cannabis market, today announced the retention of TDM Financial as its full service investor relations firm to provide online branding, marketing, outreach, and investor relations management services. TDM Finacial also owns and operates CannabisFN.com a leading financial network serving the medical marijuana (MMJ) and cannabis industries. Abattis Announces Grant Of Options
ACCESSWIRE - Mon Mar 31, 3:13PM CDT
Vancouver, BC / ACCESSWIRE / March 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), wishes to announce that it has granted incentive stock options to directors, officers and consultants of the Company to purchase up to an aggregate of 500,000 common shares of the Company. The options are exercisable on or before March 31, 2019, at an exercise price of $2.00 per share. Abattis Announces Shares For Debt Settlement
ACCESSWIRE - Mon Mar 31, 1:39PM CDT
Vancouver, BC / ACCESSWIRE / March 31, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), announces the Company has reached a debt settlement arrangement with a service provider which is related to one of its directors in relation to an aggregate of US$62,554 debt owed to the service provider. Under the terms of the agreement, the Company proposes to issue an aggregate of 43,440 shares at a deemed price of US$1.44 (approx. CAD$1.60) per share. OTC Daily Alert Stock Watch - Abattis Bioceuticals Corp. (OTC: ATTBF)
WorldStockWire - Fri Mar 28, 9:15PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
CannabisFN Weekly: Stocks Rally Ahead of Canada's MMPR Implementation
ACCESSWIRE - Mon Mar 24, 8:02AM CDT
Whitefish, MT / March 24, 2014 / The Marijuana Index™ moved lower last week due to a fall in GW Pharmaceuticals plc (OTCBB: GWPH), which accounts for 15.81% of the market capitalized weighted index, but these losses were offset by gains in many other components of the index. Investors have also been eyeing the upcoming MMPRs in Canada, which are set to become law on April 1, 2014, as well as ongoing favorable regulations in the United States.
Canadian Federal Court Judge's MMPR Injunction Very Positive for Abattis.
ACCESSWIRE - Sun Mar 23, 7:57PM CDT
Vancouver, BC / ACCESSWIRE / March 24, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), is pleased to comment on Canadian Federal judge Justice Michael D. Manson's ruling on March 21, 2014. Tranzbyte and ATTBF Sign Letters of Intent Creating Strategic Production, Sales, and Distribution Partnership
Marketwire - Fri Mar 21, 9:00AM CDT
Tranzbyte Corporation (OTC Pink: ERBB)(PINKSHEETS: ERBB) (http://www.bloomberg.com/quote/ERBB:US) announced today that it has signed a Letter of Intent to form a strategic partnership with Abattis (OTC Pink: ATTBF)(PINKSHEETS: ATTBF) (CSE: ATT) (http://www.bloomberg.com/quote/ATTBF:US) to sell, market or otherwise license one another's products in their respective regions. Once the arrangement is completed, Tranzbyte will have access to Abattis's expanding suite of bio-ceutical grow products found in the Biocube Green Grow Systems for cultivation (LED's, Nutrients - Natures Juice). In addition Abattis owns proprietary flash freeze extraction technology, which produces high-grade cannabis and other botanical extracts. Conversely, Abattis will have the Canadian rights to distribute ZaZZZ(TM) and will pair Tranzbyte's Jurassic O2 water systems with its Biocube Green Grow Systems sales efforts in the US.
Abattis Announces Closing of $2.4M Financing and Option Grant
ACCESSWIRE - Wed Mar 19, 12:43PM CDT
Vancouver, BC / ACCESSWIRE / March 19, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), is pleased to announce that further to its news release of March 4, 2014, it has now closed a non-brokered private placement of 5,333,333 units for gross proceeds of $2.4M. Abattis Corporate Update
ACCESSWIRE - Tue Mar 18, 9:49PM CDT
Vancouver, BC / ACCESSWIRE / March 18, 2014 / Abattis Bioceuticals Corp. (the "Company" or "Abattis"
(OTC PINK: ATTBF) (CSE: ATT), wishes to provide a corporate update to inform shareholders of managements activities and focus. 
